Can Theranos survive its ‘dramatic retreat’ and brand crisis?
A ‘pivot’ that will shutter clinical labs and bring massive layoffs raises doubts about its future. Meanwhile, the journalist who broke the story about flawed blood testing is being celebrated.
Business Insider reported the Silicon Valley-based company—led by Elizabeth Holmes—is regrouping.
Almost a year after The Wall Street Journal published an investigation that questioned the accuracy of Theranos’ blood test, the company has decided to stop all of its clinical operations, cutting 340 positions and closing its Wellness Centers where blood tests were performed.
Become a Ragan Insider member to read this article and all other archived content.
Sign up today
Already a member? Log in here.
Learn more about Ragan Insider.
